| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.54e-10 | 37 | 83 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.88e-10 | 38 | 83 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.96e-08 | 11 | 83 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.69e-07 | 14 | 83 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.57e-06 | 21 | 83 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.65e-05 | 37 | 83 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 1.71e-05 | 2 | 83 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.84e-05 | 38 | 83 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.96e-05 | 46 | 83 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.34e-04 | 29 | 83 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.29e-04 | 79 | 83 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 3.54e-04 | 7 | 83 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 TPP2 VASH2 ERVK-18 BACE1 ERVK-7 ERVK-25 NCSTN ERVK-10 CPVL | 3.75e-04 | 654 | 83 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.17e-04 | 430 | 83 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.64e-04 | 105 | 83 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | serine-type exopeptidase activity | 1.10e-03 | 12 | 83 | 2 | GO:0070008 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 MET PGS1 MAST4 TIE1 PAK5 PAK4 ERVK-7 ERVK-10 ERVK-11 MAP3K4 | 1.69e-03 | 938 | 83 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.72e-03 | 207 | 83 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 1.73e-03 | 15 | 83 | 2 | GO:0008020 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.76e-03 | 208 | 83 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 2.23e-03 | 17 | 83 | 2 | GO:0009881 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.50e-03 | 136 | 83 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.50e-03 | 136 | 83 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.77e-03 | 231 | 83 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | proteasome binding | 3.09e-03 | 20 | 83 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.72e-03 | 152 | 83 | 4 | GO:0016779 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 3.74e-03 | 22 | 83 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 4.08e-03 | 23 | 83 | 2 | GO:0005283 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.54e-07 | 13 | 81 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.88e-05 | 83 | 81 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.77e-05 | 48 | 81 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | branching involved in lymph vessel morphogenesis | 4.56e-05 | 3 | 81 | 2 | GO:0060854 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein biosynthetic process | 9.09e-05 | 4 | 81 | 2 | GO:0042986 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 1.51e-04 | 5 | 81 | 2 | GO:0045053 | |
| Domain | Alg10 | 1.72e-05 | 2 | 78 | 2 | IPR016900 | |
| Domain | DIE2_ALG10 | 1.72e-05 | 2 | 78 | 2 | PF04922 | |
| Domain | VPS13 | 5.15e-05 | 3 | 78 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 5.15e-05 | 3 | 78 | 2 | PF16910 | |
| Domain | VPS13 | 5.15e-05 | 3 | 78 | 2 | PF16908 | |
| Domain | VPS13_N2 | 5.15e-05 | 3 | 78 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 5.15e-05 | 3 | 78 | 2 | IPR031642 | |
| Domain | VPS13_C | 1.03e-04 | 4 | 78 | 2 | PF16909 | |
| Domain | SHR-BD | 1.03e-04 | 4 | 78 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.03e-04 | 4 | 78 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.03e-04 | 4 | 78 | 2 | PF06650 | |
| Domain | PAK_BD | 2.55e-04 | 6 | 78 | 2 | IPR033923 | |
| Domain | WASP_C | 3.57e-04 | 7 | 78 | 2 | IPR011026 | |
| Domain | VPS13_N | 4.74e-04 | 8 | 78 | 2 | IPR026854 | |
| Domain | Chorein_N | 4.74e-04 | 8 | 78 | 2 | PF12624 | |
| Domain | fn3 | 5.85e-04 | 162 | 78 | 5 | PF00041 | |
| Domain | FN3 | 1.06e-03 | 185 | 78 | 5 | SM00060 | |
| Domain | - | 1.11e-03 | 12 | 78 | 2 | 3.90.810.10 | |
| Domain | ABC_A | 1.11e-03 | 12 | 78 | 2 | IPR026082 | |
| Domain | ASP_PROTEASE | 1.11e-03 | 12 | 78 | 2 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 1.30e-03 | 13 | 78 | 2 | IPR001969 | |
| Domain | FN3 | 1.47e-03 | 199 | 78 | 5 | PS50853 | |
| Domain | FN3_dom | 1.82e-03 | 209 | 78 | 5 | IPR003961 | |
| Domain | PBD | 1.99e-03 | 16 | 78 | 2 | SM00285 | |
| Domain | PBD | 2.25e-03 | 17 | 78 | 2 | PF00786 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 2.52e-03 | 18 | 78 | 2 | PS00754 | |
| Domain | SNF | 2.81e-03 | 19 | 78 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.81e-03 | 19 | 78 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.81e-03 | 19 | 78 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 2.81e-03 | 19 | 78 | 2 | IPR000175 | |
| Domain | CRIB | 3.12e-03 | 20 | 78 | 2 | PS50108 | |
| Domain | CRIB_dom | 3.43e-03 | 21 | 78 | 2 | IPR000095 | |
| Domain | zf-CCHC | 4.12e-03 | 23 | 78 | 2 | PF00098 | |
| Domain | IPT | 5.65e-03 | 27 | 78 | 2 | SM00429 | |
| Domain | TIG | 7.40e-03 | 31 | 78 | 2 | PF01833 | |
| Domain | IPT | 7.87e-03 | 32 | 78 | 2 | IPR002909 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 4.10e-06 | 62 | 55 | 5 | M45532 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.83e-08 | 4 | 86 | 3 | 10469592 | |
| Pubmed | 1.04e-07 | 18 | 86 | 4 | 18664271 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.31e-07 | 94 | 86 | 6 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.45e-07 | 5 | 86 | 3 | 12629516 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 5.73e-06 | 47 | 86 | 4 | 19167335 | |
| Pubmed | Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. | 6.04e-06 | 2 | 86 | 2 | 17980964 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 12054507 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 6.04e-06 | 2 | 86 | 2 | 11672541 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | VPS13D MAST4 RPTOR PAK5 PAK4 DOCK7 GAN RTKN DDX41 UTRN DCAF7 | 9.07e-06 | 861 | 86 | 11 | 36931259 |
| Pubmed | 1.52e-05 | 446 | 86 | 8 | 24255178 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24303013 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 27565738 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 10516026 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22086926 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 9971820 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 20607864 | ||
| Pubmed | p120-catenin is a binding partner and substrate for Group B Pak kinases. | 1.81e-05 | 3 | 86 | 2 | 20564219 | |
| Pubmed | The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. | 1.81e-05 | 3 | 86 | 2 | 22692213 | |
| Pubmed | Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. | 1.81e-05 | 3 | 86 | 2 | 14681302 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25100642 | ||
| Pubmed | Evaluation of the ELOVL4, PRPH2 and ABCA4 genes in patients with Stargardt macular degeneration. | 1.81e-05 | 3 | 86 | 2 | 22948568 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 20704561 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 15498460 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 12808150 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 3.61e-05 | 4 | 86 | 2 | 14525949 | |
| Pubmed | Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. | 3.61e-05 | 4 | 86 | 2 | 22547652 | |
| Pubmed | A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer's disease. | 3.61e-05 | 4 | 86 | 2 | 25863267 | |
| Pubmed | BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains. | 3.61e-05 | 4 | 86 | 2 | 29979789 | |
| Pubmed | PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. | 3.61e-05 | 4 | 86 | 2 | 11756552 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 22404908 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 7983737 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 20070256 | ||
| Pubmed | 5.10e-05 | 529 | 86 | 8 | 14621295 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.01e-05 | 5 | 86 | 2 | 11401426 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 24711622 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 14717705 | ||
| Pubmed | Targeted disruption of the gene for the PAK5 kinase in mice. | 9.01e-05 | 6 | 86 | 2 | 14517284 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 15044949 | ||
| Pubmed | mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). | 1.26e-04 | 7 | 86 | 2 | 24870234 | |
| Pubmed | An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease. | 1.68e-04 | 8 | 86 | 2 | 25592972 | |
| Pubmed | Spatial segregation of gamma-secretase and substrates in distinct membrane domains. | 1.68e-04 | 8 | 86 | 2 | 15886206 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.44e-04 | 1038 | 86 | 10 | 26673895 | |
| Pubmed | The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. | 3.28e-04 | 11 | 86 | 2 | 11894096 | |
| Pubmed | Transcriptomic analysis of murine embryos lacking endogenous retinoic acid signaling. | 3.28e-04 | 11 | 86 | 2 | 23638021 | |
| Pubmed | Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. | 3.93e-04 | 12 | 86 | 2 | 15467718 | |
| Pubmed | Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes. | 3.93e-04 | 12 | 86 | 2 | 28204537 | |
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 4.63e-04 | 13 | 86 | 2 | 15491607 | |
| Pubmed | Linkage and association of successful aging to the 6q25 region in large Amish kindreds. | 4.63e-04 | 13 | 86 | 2 | 22773346 | |
| Pubmed | 5.36e-04 | 150 | 86 | 4 | 32423001 | ||
| Pubmed | Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling. | 5.39e-04 | 14 | 86 | 2 | 31319059 | |
| Pubmed | Tie1 is required for lymphatic valve and collecting vessel development. | 5.39e-04 | 14 | 86 | 2 | 25576926 | |
| Pubmed | 6.21e-04 | 15 | 86 | 2 | 1538749 | ||
| Pubmed | Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling. | 7.09e-04 | 16 | 86 | 2 | 24697899 | |
| Pubmed | 7.09e-04 | 16 | 86 | 2 | 28283561 | ||
| Pubmed | 7.49e-04 | 164 | 86 | 4 | 32409323 | ||
| Pubmed | Assignment of 22 loci in the rat by somatic hybrid and linkage analysis. | 9.01e-04 | 18 | 86 | 2 | 8268657 | |
| Pubmed | Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking. | 9.01e-04 | 18 | 86 | 2 | 26598607 | |
| Pubmed | 1.01e-03 | 19 | 86 | 2 | 7558022 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 1.23e-03 | 21 | 86 | 2 | 16125675 | |
| Pubmed | 1.35e-03 | 22 | 86 | 2 | 18628988 | ||
| Pubmed | Klf2 is an essential regulator of vascular hemodynamic forces in vivo. | 1.35e-03 | 22 | 86 | 2 | 17141159 | |
| Pubmed | 1.44e-03 | 1084 | 86 | 9 | 11544199 | ||
| Pubmed | 1.48e-03 | 23 | 86 | 2 | 12955145 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.56e-03 | 1321 | 86 | 10 | 27173435 | |
| Pubmed | 1.56e-03 | 92 | 86 | 3 | 20301317 | ||
| Pubmed | 1.83e-03 | 209 | 86 | 4 | 36779422 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.87e-03 | 910 | 86 | 8 | 36736316 | |
| Pubmed | 1.89e-03 | 26 | 86 | 2 | 33238123 | ||
| Pubmed | 2.03e-03 | 215 | 86 | 4 | 35973513 | ||
| Pubmed | Interspecific backcrosses provide an important new tool for centromere mapping of mouse chromosomes. | 2.04e-03 | 27 | 86 | 2 | 8188294 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 2.04e-03 | 27 | 86 | 2 | 23027611 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.10e-03 | 102 | 86 | 3 | 15778465 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.16e-03 | 536 | 86 | 6 | 15840001 | |
| Pubmed | 2.19e-03 | 28 | 86 | 2 | 18593464 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 2.19e-03 | 28 | 86 | 2 | 35227662 | |
| Pubmed | 2.20e-03 | 538 | 86 | 6 | 10512203 | ||
| Interaction | CBY1 interactions | 7.96e-06 | 182 | 80 | 7 | int:CBY1 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 8.43e-06 | 2 | 53 | 2 | 448 | |
| GeneFamily | Fibronectin type III domain containing | 1.04e-04 | 160 | 53 | 5 | 555 | |
| GeneFamily | ATP binding cassette subfamily A | 7.50e-04 | 14 | 53 | 2 | 805 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-08 | 185 | 80 | 7 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 161 | 80 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 170 | 80 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 170 | 80 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-05 | 179 | 80 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 181 | 80 | 5 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 183 | 80 | 5 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 187 | 80 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-05 | 189 | 80 | 5 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-05 | 190 | 80 | 5 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.43e-05 | 191 | 80 | 5 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 191 | 80 | 5 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 191 | 80 | 5 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-05 | 191 | 80 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-05 | 192 | 80 | 5 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 193 | 80 | 5 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.75e-05 | 196 | 80 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.75e-05 | 196 | 80 | 5 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.75e-05 | 196 | 80 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 197 | 80 | 5 | b17ac6c88dc53e54e04e8a79409d9a0de0be88dc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 197 | 80 | 5 | a22c0f2ffac34635c9c8221aee778e2fc78d672b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-05 | 198 | 80 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-05 | 199 | 80 | 5 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 137 | 80 | 4 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | control-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.43e-04 | 147 | 80 | 4 | 68258498202c7f580f72c46dd645071835098455 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.84e-04 | 157 | 80 | 4 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | Control-Lymphocyte-T_NK-dnT|Control / Disease, Lineage and Cell Type | 1.88e-04 | 158 | 80 | 4 | 7a2fad6426549d910834debfe5e102fe2ab5976d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-04 | 161 | 80 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.12e-04 | 163 | 80 | 4 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 164 | 80 | 4 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 164 | 80 | 4 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-04 | 165 | 80 | 4 | 5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 166 | 80 | 4 | 941d6aa94ab9d36e5f6c40f446c926754e070d56 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 166 | 80 | 4 | 6f5ecf3b2cf613ae0535ab3d21d93622f1497571 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 169 | 80 | 4 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 170 | 80 | 4 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.49e-04 | 170 | 80 | 4 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 171 | 80 | 4 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 2.60e-04 | 172 | 80 | 4 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.60e-04 | 172 | 80 | 4 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.66e-04 | 173 | 80 | 4 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-04 | 173 | 80 | 4 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.72e-04 | 174 | 80 | 4 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.72e-04 | 174 | 80 | 4 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.72e-04 | 174 | 80 | 4 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 2.78e-04 | 175 | 80 | 4 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.84e-04 | 176 | 80 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.84e-04 | 176 | 80 | 4 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-04 | 176 | 80 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 176 | 80 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.90e-04 | 177 | 80 | 4 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-04 | 177 | 80 | 4 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.96e-04 | 178 | 80 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 2.96e-04 | 178 | 80 | 4 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 178 | 80 | 4 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.03e-04 | 179 | 80 | 4 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 179 | 80 | 4 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 179 | 80 | 4 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.03e-04 | 179 | 80 | 4 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-04 | 179 | 80 | 4 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.03e-04 | 179 | 80 | 4 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-04 | 180 | 80 | 4 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.09e-04 | 180 | 80 | 4 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 181 | 80 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.16e-04 | 181 | 80 | 4 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.16e-04 | 181 | 80 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 181 | 80 | 4 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-04 | 182 | 80 | 4 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.22e-04 | 182 | 80 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.22e-04 | 182 | 80 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 3.22e-04 | 182 | 80 | 4 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-04 | 182 | 80 | 4 | c3eafdc11858566aa7692b2f5dbe72ac01fb769a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.22e-04 | 182 | 80 | 4 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 182 | 80 | 4 | 82d6f72649c7dd4d64a84a9795edebdef2f285d6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 182 | 80 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-04 | 182 | 80 | 4 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.22e-04 | 182 | 80 | 4 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-04 | 183 | 80 | 4 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-04 | 183 | 80 | 4 | c7fedb5b0c1f17b3391ce1c4a6bfca7615c359c5 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.29e-04 | 183 | 80 | 4 | 797eb968c57e48db33ff8e2236ee22e9425c4676 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.29e-04 | 183 | 80 | 4 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.36e-04 | 184 | 80 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.43e-04 | 185 | 80 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-04 | 185 | 80 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-04 | 185 | 80 | 4 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.43e-04 | 185 | 80 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 186 | 80 | 4 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 186 | 80 | 4 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 186 | 80 | 4 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 187 | 80 | 4 | dd5183d2c620b2a87253a9783b70c5df2c36c570 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-04 | 187 | 80 | 4 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| Disease | Stargardt disease (implicated_via_orthology) | 6.72e-06 | 2 | 77 | 2 | DOID:0050817 (implicated_via_orthology) | |
| Disease | Stargardt disease | 2.01e-05 | 3 | 77 | 2 | cv:C0271093 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 2.01e-05 | 3 | 77 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Long Qt Syndrome 2 | 2.01e-05 | 3 | 77 | 2 | C3150943 | |
| Disease | STARGARDT DISEASE 1 (disorder) | 6.69e-05 | 5 | 77 | 2 | C1855465 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 1.00e-04 | 6 | 77 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | Stargardt's disease | 1.00e-04 | 6 | 77 | 2 | C0271093 | |
| Disease | glutamine measurement | 1.24e-04 | 97 | 77 | 4 | EFO_0009768 | |
| Disease | Thyroid preparation use measurement | 2.64e-04 | 217 | 77 | 5 | EFO_0009933 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.36e-04 | 12 | 77 | 2 | OBA_2045152 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 5.15e-04 | 13 | 77 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.72e-04 | 157 | 77 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | 1.14e-03 | 1206 | 77 | 10 | EFO_0004458 | |
| Disease | coagulation factor V measurement | 1.24e-03 | 20 | 77 | 2 | EFO_0008087 | |
| Disease | leptin measurement | 1.26e-03 | 81 | 77 | 3 | EFO_0005000 | |
| Disease | body weight | 1.59e-03 | 1261 | 77 | 10 | EFO_0004338 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.64e-03 | 23 | 77 | 2 | C1708353 | |
| Disease | beta-aminoisobutyric acid measurement | 1.79e-03 | 24 | 77 | 2 | EFO_0010464 | |
| Disease | amino acid measurement | 1.96e-03 | 678 | 77 | 7 | EFO_0005134 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.10e-03 | 206 | 77 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.11e-03 | 97 | 77 | 3 | EFO_0007878, EFO_0009458 | |
| Disease | Vitiligo | 2.37e-03 | 101 | 77 | 3 | EFO_0004208 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WPDMGVPEYALPVLT | 1026 | P23470 | |
| TPWNIFPVISLYLMG | 336 | P56817 | |
| WVSMQPQPLLPPTYF | 901 | A0A096LP49 | |
| VVFPDMYPWTSSLPP | 551 | P78363 | |
| LPMLEKCWYPTSVPV | 336 | O14503 | |
| LWMEPTQPPDFALAY | 396 | Q9HCU0 | |
| YWLASAAPLPMMPLS | 1541 | P53420 | |
| VEPMLWNPSGTPKRY | 221 | O95567 | |
| SQWDPMITTLPGLYL | 56 | Q5I7T1 | |
| YPMVTGTLPKAQSWP | 161 | Q9Y2E6 | |
| DHPYPTTKLMWIPDT | 66 | P61962 | |
| MSWLTLTLPEQPEAP | 336 | Q8NCT1 | |
| PTCMVWYPPLTRELF | 796 | Q8TBY9 | |
| WELSPANYMKTLPPD | 141 | O75901 | |
| IEPSCPMKPLYWTRI | 976 | Q68DA7 | |
| ALMPIIGWASYAPDP | 156 | O14718 | |
| DLQWVLTDGPNPPYM | 81 | Q92542 | |
| TPYWMAPEVISRLPY | 606 | Q9P286 | |
| PLWNKLTYMWPVLPS | 886 | M0R2J8 | |
| PLMQSPWPTLSISTL | 41 | Q9GZR5 | |
| SGMRVPKSLPYVLPW | 146 | Q8WW33 | |
| YLMPILPVPSSSWED | 1726 | Q6ZU64 | |
| PWTTTLSMLYIDNPV | 141 | Q9H3G5 | |
| YPLLSSPVQWPLSLV | 16 | B1ANH7 | |
| MTVLAPAWSPTTYLL | 1 | P49771 | |
| APDTWIYPLIQMKPF | 346 | Q32NB8 | |
| WYQSMIPQSPSPPLD | 651 | Q07343 | |
| PFESPIWRMYPNSTV | 151 | Q96PG2 | |
| SYMSPTLPALDWQLP | 406 | O95644 | |
| NWIRPTLGIPTYVMS | 276 | P63132 | |
| HTMLSSPLEYLPPWD | 76 | Q9UL01 | |
| PPSAEPLRIYWMNSK | 161 | P32004 | |
| WIMTPSTLPPLEVYV | 296 | Q9ULW8 | |
| PIKTSWTPPRYVLSM | 141 | Q9UJV9 | |
| MPFAAPPQSPTWLLY | 366 | Q8WWR8 | |
| NWIRPTLGIPTYAMS | 276 | P63135 | |
| NWIRPTLGIPTYAMS | 276 | Q9BXR3 | |
| IWYVEAMTQDLPSPP | 376 | O77932 | |
| PPAPWTILGLDAMYV | 256 | O15118 | |
| NWIRPTLGIPTYAMS | 276 | Q9QC07 | |
| LTYMGLQPPKLWPES | 226 | A1A4V9 | |
| TPLETPVGYTWIPML | 661 | Q96N67 | |
| KYDPDANTWTALPPM | 346 | Q9H2C0 | |
| PLSPHITIYSWSLPM | 51 | Q99643 | |
| ITPIMYPASFWFEVP | 1886 | Q9BZC7 | |
| TYGILPPFIWTLLMP | 231 | P56937 | |
| MNKSYLLEPWFLPPS | 1866 | O15021 | |
| WLPPPETPMTSHIRY | 166 | P19235 | |
| PPGDTTTIIPLNWML | 16 | Q6ZN92 | |
| SFLNPLSPDIWMYVL | 556 | Q13003 | |
| WMAPELISRLPYGPE | 481 | O96013 | |
| TSAPAPNAYTMPPLW | 156 | Q3SX64 | |
| PMWGSDYVQLSRTPP | 576 | Q9Y6R4 | |
| VLLWELMTRGAPPYP | 1271 | P08581 | |
| LETPPPWLAMFTDQP | 476 | Q9BST9 | |
| YVPSTPWFLMPILVE | 196 | Q9NYV6 | |
| PITLISMWPEHYDPS | 3166 | P46939 | |
| LAMSWIKPQLQLYPP | 1986 | A0AVI2 | |
| WDEGYSTPSIPPEML | 561 | P0DPF3 | |
| LMMILSVYSPPLPWI | 486 | Q8IVM8 | |
| DDFWTIPPLTQPFML | 301 | Q5VZ19 | |
| LITVYSLPGMDPDWL | 361 | Q9NR46 | |
| ASLMPPIWDKTIPYD | 76 | Q10587 | |
| IEFPLSATAPMVWLP | 1371 | Q12769 | |
| PLSIYDLQTWMGSPS | 176 | Q8N122 | |
| YPQAMTMLPLSPFWS | 371 | Q99884 | |
| EGIPYPSNLPLMANW | 236 | Q495N2 | |
| QIGPSLLPIMWQLYP | 66 | P56279 | |
| SQWDPMITTLPGLYL | 56 | Q5BKT4 | |
| PDLTLSYLSMWLHQP | 176 | Q9BW66 | |
| NWIRPTLGIPTYAMS | 276 | P63136 | |
| SMPAYDRISPPWALE | 376 | Q9Y2H5 | |
| LYMWDSVLPPENILS | 176 | P02743 | |
| PDSWQPPNVYLETSM | 6 | Q9Y3C6 | |
| WTETYPQTPPILSMN | 51 | Q6NW29 | |
| TLMTTDCPEPLLQPW | 536 | P35590 | |
| PPPATLSQLLEVMSW | 486 | Q14765 | |
| AYPRAVVMLPFSPLW | 361 | Q9NSD5 | |
| NWIRPTLGIPTYAMS | 276 | P10266 | |
| ASFTENWLPIMYPPD | 1231 | P29144 | |
| NWIRPTLGIPTYAMS | 276 | Q9UQG0 | |
| PQVPNYRLSMTIPDW | 96 | Q86V25 | |
| PALIMNHTPWDILTY | 2976 | Q709C8 | |
| LSSPYDVPTWMPQLL | 1771 | Q14997 | |
| WVVSQPPDTYLKPLM | 476 | Q92973 | |
| GLLSLLPSMPLNWPY | 466 | O76024 | |
| MTSLDYAWDEPTLPP | 3546 | Q5THJ4 | |
| LLYNSTDPTLRAMWP | 546 | B0I1T2 | |
| TSLVLQWEPPLYMGA | 816 | Q5VTT5 |